🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to all who attended our #NarrativeMedicine session at #ACRO2024. Could not have asked for a better team to help facilitate this! Matthew J. Farrell Eulanca Liu ACROresident ACRO - American College of Radiation Oncology

Congratulations to our residents on their presentations at #ACRO2024 today! Mohamed Abdelhakiem, MD - Shadyside Foundation Grant, Baher Elgohari - ACRO BEST Award, Ria Mulherkar Kraft, MD - UPMC GME Grant UPMC Hillman Cancer Center Heath Skinner, MD PhD

Happy #MatchDay2024! We are thrilled to welcome Dr. Abigail Groszkiewicz and Dr. Reeny Thomas to our #radonc program UPMC Hillman Cancer Center!! Congrats to Abby & Reeny & all the hardworking students who are moving on to the next steps in training! Heath Skinner, MD PhD

Congratulations to Dr. Diala Hamade on her presentation on the final day of #ACRO2024! Parul Barry Heath Skinner, MD PhD

Since we were founded, ROI has funded more than $4.3 million to accelerate research and education to help people living with cancer live longer, happier lives. Join our team by donating at ROInstitute.org/donate. Because every month is #NationalCancerResearchMonth

Enjoyed participating in this great virtual seminar on vestibular schwannomas. Fantastic multi-disciplinary talks. Honored to be speaking about the role of radiotherapy with Dr. Dade Lunsford and Dr. Helen Shih. UPMC Hillman Cancer Center Pitt Center for Image-Guided Neurosurgery

Check out this great article featuring Dr. Health Skinner from UPMC Hillman Cancer Center discussing the potential for SCINTIX biology-guided radiotherapy, which is cleared to treat tumors in the lung or bone that arise from primary or metastatic disease. linkedin.com/feed/update/ur…

Phase I results from our study of RT + IT T/P for HER2+ LMD now online JAMA Oncology. Phase II study currently open Moffitt Cancer Center and Lurie Cancer Center. Great collaborative effort! Peter Forsyth Yoly (Yolanda) Pina Michael Vogelbaum Daniel (Donny) Oliver James K. C. Liu MoffittRadOnc James Caudell

Impressive advantage of PCV over TMZ in oligodendroglioma presented by ⁦⁦Mehdi Touat⁩ #asco24

Excellent talk on brain metastases by Dr. Minesh Mehta at #ASCO24 There are now some systemic therapies that work great in the CNS. Unfortunately they only work for a small proportion of cancers that spread to the brain. #RT especially #SRS is the standard therapy for most.

Dr. Uzoma Iheagwara (Uzoma K. Iheagwara, MD, PhD) our Director of Radiation Oncology Clinical Trials – Community is leading a project focused on identifying and overcoming barriers to HNC clinical trial access and enrollment in rural and minority populations served by the our radiation oncology

Happy to share free #CME from our own UPMC Hillman Cancer Center Dr. Tyler Wilhite about low dose #radiation for #arthritis. This treatment is offered at many sites in our network and is complimentary to other therapies for OA. upmcphysicianresources.com/cme-courses/lo…

PET/CT Superior to MRI for Lesion Detection in Head and Neck Paragangliomas Read more ➡️ bit.ly/3RqGIVf SNMMI #RadOncNews #snmmi24 #PETCT #HNC #NucMed #HeadAndNeckCancer

Only 1 week remains to apply for the 2024 ROI Publication Excellence Awards and the ARRO DEI Publication Award! Nominate an early career #radonc researcher to win $1,500 and be recognized at #ASTRO24. Details at bit.ly/ROI_Publicatio…. Self nominations accepted.

⚡️⚡️⚡️Reduced-dose CSI (15 Gy), focal boost (51 Gy) with 0.5 cm margin followed by reduced adjuvant chemotherapy (only 4 cycles) in non-metastatic WNT medulloblastoma yield an impressive 5-year OS of 98.6% (!!), as per the SJMB12 phase 2 trial #ISPNO2024

Welcome New UPMC Hillman Cancer Center Doctors | Welcome ⁦BhanuPrasad Venkatesulu⁩!!!@johnavargo76687 ⁦Heath Skinner, MD PhD⁩ ⁦Magee-Womens Research Institute & Foundation⁩ ⁦UPMC Hillman Cancer Center⁩ upmcphysicianresources.com/specialties/on…

Journal of Clinical Oncology: TURBO-NSCLC (ascopubs.org/doi/10.1200/JC…) was a multi-institutional cohort study of 317 treatment-naive EGFR or ALK NSCLC pts with Brain Mets who received TKI w/wo up-front SRS. SRS was associated with superior CNS control. Memorial Sloan Kettering Radiation Oncology Memorial Sloan Kettering Cancer Center

Congratulations Laura!

Many thanks to the hundreds of #womenwhocurie who shared their personal experiences for this research. We hope that by publishing this work, we shine a light on the deeply toxic culture that limits both the careers & families of so many #womeninMedicine. acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Excited for this excellent series! ⁦UPMC Hillman Cancer Center⁩ ⁦Magee-Womens Research Institute & Foundation⁩ ⁦Heath Skinner, MD PhD⁩ #bcsm